Cardiac tissue engineering and regeneration using cell-based therapy

References

• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• BeltramiAPUrbanekKKajsturaJEvidence that human cardiac myocytes divide after myocardial infarctionN Eng J Med20013442317501757
   PubMed Web of Science ®Google Scholar
• ReddiAHHugginsCBInfluence of geometry of transplanted tooth and bone on transformation of fibroblastsProc Soc Exp Biol Med197314336346374578252
   PubMed Web of Science ®Google Scholar
• OttHCMatthiesenTSGohSKPerfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heartNat Med200814221322118193059
   PubMed Web of Science ®Google Scholar
• PaschosNKBrownWEEswaramoorthyRHuJCAthanasiouKAAdvances in tissue engineering through stem cell-based co-cultureJ Tissue Eng Regen Med2014 Epub23
   Web of Science ®Google Scholar
• ScorsinMHagegeAAMarotteFDoes transplantation of cardiomyocytes improve function of infarcted myocardium?Circulation1997969 SupplII-188II-193
   Web of Science ®Google Scholar
• LiRKJiaZQWeiselRDCardiomyocyte transplantation improves heart functionAnn Thorac Med1996623654660
   Google Scholar
• XuCPoliceSRaoNCarpenterMKCharacterization and enrichment of cardiomyocytes derived from human embryonic stem cellsCirc Res200291650150812242268
   PubMed Web of Science ®Google Scholar
• LeeASTangCCaoFEffects of cell number on teratoma formation by human embryonic stem cellsCell Cycle20098162608261219597339
   PubMed Web of Science ®Google Scholar
• GluckmanETen years of cord blood transplantation: from bench to bedsideBr J Haematol2009147219219919796268
   PubMed Web of Science ®Google Scholar
• HenningRJBurgosJDVaskoMHuman cord blood cells and myocardial infarction: effect of dose and route of administration on infarct sizeCell Transplant200716990791718293889
   PubMed Web of Science ®Google Scholar
• WangLDengJTianWAdipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat heartsAm J Physiol Heart Circ Physiol20092973H1020H103119574490
   PubMed Web of Science ®Google Scholar
• ValinaCPinkernellKSongYHIntracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarctionEur Heart J200728212667267717933755
   PubMed Web of Science ®Google Scholar
• TaylorDAAtkinsBZHungspreugsPRegenerating functional myocardium: improved performance after skeletal myoblast transplantationNat Med1998489299339701245
   PubMed Web of Science ®Google Scholar
• MenaschéPAlfieriOJanssensSThe Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantationCirculation200811791189120018285565
   PubMed Web of Science ®Google Scholar
• DibNMichlerREPaganiFDSafety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-upCirculation2005112121748175516172284
   PubMed Web of Science ®Google Scholar
• OrlicDKajsturaJChimentiCBone marrow cells regenerate infarcted myocardiumNature2001410682970170511287958
   PubMed Web of Science ®Google Scholar
• LaflammeMAChenKYNaumovaAVCardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat heartsNat Biotechnol20072591015102417721512
   PubMed Web of Science ®Google Scholar
• BeltramiAPBarlucchiLTorellaDAdult cardiac stem cells are multipotent and support myocardial regenerationCell2003114676377614505575
   PubMed Web of Science ®Google Scholar
• MessinaEDe AngelisLFratiGIsolation and expansion of adult cardiac stem cells from human and murine heartCirc Res200495991192115472116
   PubMed Web of Science ®Google Scholar
• OhHBradfuteSBGallardoTDCardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarctionProc Natl Acad Sci U S A200310021123131231814530411
   PubMed Web of Science ®Google Scholar
• BeltramiAPAdult cardiac stem cells are multipotent and support myocardial regenerationCell2003114676377614505575
   PubMed Web of Science ®Google Scholar
• WeissmanILAndersonDJGageFStem and progenitor cells: origins, phenotypes, lineage commitments, and trans-differentiationsAnnu Rev Cell Dev Biol20011738740311687494
   PubMed Web of Science ®Google Scholar
• TangXLRokoshGSanganalmathSKIntracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarctionCirculation2010121229330520048209
   PubMed Web of Science ®Google Scholar
• BearziCRotaMHosodaTHuman cardiac stem cellsProc Natl Acad Sci U S A200710435140681407317709737
   PubMed Web of Science ®Google Scholar
• LinkeAMüllerPNurzynskaDStem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac functionProc Natl Acad Sci U S A2005102258966897115951423
   PubMed Web of Science ®Google Scholar
• UrbanekKCesselliDRotaMStem cell niches in the adult mouse heartProc Natl Acad Sci U S A2006103249226923116754876
   PubMed Web of Science ®Google Scholar
• BolliRChughARD’AmarioDCardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialLancet201137898061847185722088800
   PubMed Web of Science ®Google Scholar
• Pérez-PomaresJMde la PompaJLSignaling during epicardium and coronary vessel developmentCirc Res2011109121429144222158650
   PubMed Web of Science ®Google Scholar
• TianXHuTZhangHSubepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteriesCell Res20132391075109023797856
   PubMed Web of Science ®Google Scholar
• CossetteSMisraRThe identification of different endothelial cell populations within the mouse proepicardiumDev Dyn2011240102344235321932312
   PubMed Web of Science ®Google Scholar
• TomanekRJFormation of the coronary vasculature: a brief reviewCardiovasc Res199631Spec NoE46E518681345
   PubMed Web of Science ®Google Scholar
• KattmanSJWittyADGagliardiMStage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell linesCell Stem Cell20118222824021295278
   PubMed Web of Science ®Google Scholar
• YeLZimmermannWHGarryDJZhangJPatching the heart: cardiac repair from within and outsideCirc Res2013113792293224030022
   PubMed Web of Science ®Google Scholar
• LiRKJiaZQWeiselRDMickleDAChoiAYauTMSurvival and function of bioengineered cardiac graftsCirculation199910019 SupplII63II6910567280
   PubMed Web of Science ®Google Scholar
• ThomsonJAItskovitz-EldorJShapiroSSEmbryonic stem cell lines derived from human blastocystsScience19982825391114511479804556
   PubMed Web of Science ®Google Scholar
• YangLSoonpaaMHAdlerEDHuman cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived populationNature2008453719452452818432194
   PubMed Web of Science ®Google Scholar
• BurridgePWKellerGGoldJDWuJCProduction of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogrammingCell Stem Cell2012101162822226352
   PubMed Web of Science ®Google Scholar
• PaigeSLOsugiTAfanasievOKPabonLReineckeHMurryCEEndogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cellsPloS One201056e1113420559569
   PubMed Web of Science ®Google Scholar
• UenoSWeidingerGOsugiTBiphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cellsProc Natl Acad Sci U S A2007104239685969017522258
   PubMed Web of Science ®Google Scholar
• NaitoATShiojimaIAkazawaHDevelopmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesisProc Natl Acad Sci U S A200610352198121981717170140
   PubMed Web of Science ®Google Scholar
• LianXHsiaoCWilsonGRobust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProc Natl Acad Sci U S A201210927E1848E185722645348
   PubMed Web of Science ®Google Scholar
• QianLHuangYSpencerCIIn vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytesNature2012485740059359822522929
   PubMed Web of Science ®Google Scholar
• SongKNamYJLuoXHeart repair by reprogramming non-myocytes with cardiac transcription factorsNature2012485740059960422660318
   PubMed Web of Science ®Google Scholar
• ChenJXKraneMDeutschMAWangLRav-AchaMInefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5Circ Res20121111505522581928
   PubMed Web of Science ®Google Scholar
• AddisRCEpsteinJAInduced regeneration – the progress and promise of direct reprogramming for heart repairNat Med201319782983623836233
   PubMed Web of Science ®Google Scholar
• KimCMajdiMXiaPNon-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiationStem Cells Dev201019678379520001453
   PubMed Web of Science ®Google Scholar
• PasumarthiKBFieldLJCardiomyocyte enrichment in differentiating ES cell cultures: strategies and applicationsMethods Mol Biol200218515716811768986
   PubMedGoogle Scholar
• AndersonDSelfTMellorIRGohGHillSJDenningCTransgenic enrichment of cardiomyocytes from human embryonic stem cellsMol Ther200715112027203617895862
   PubMed Web of Science ®Google Scholar
• UosakiHFukushimaHTakeuchiAEfficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expressionPloS One201168e2365721876760
   PubMed Web of Science ®Google Scholar
• DuboisNCCraftAMSharmaPSIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cellsNat Biotechnol201129111011101822020386
   PubMed Web of Science ®Google Scholar
• TohyamaSHattoriFSanoMDistinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytesCell Stem Cell201312112713723168164
   PubMed Web of Science ®Google Scholar
• FernandesSNaumovaAVZhuWZLaflammeMAGoldJMurryCEHuman embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in ratsJ Mol Cell Cardiol201049694194920854826
   PubMed Web of Science ®Google Scholar
• Writing Group MembersLloyd-JonesDAdamsRJAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2010 update: a report from the American Heart AssociationCirculation20101217e46e21520019324
   PubMed Web of Science ®Google Scholar
• RumyantsevPPGrowth and Hyperplasia of Cardiac Muscle Cells1st edLondonTaylor and Francis19911371
   Google Scholar
• SoonpaaMHFieldLJSurvey of studies examining mammalian cardiomyocyte DNA synthesisCirc Res199883115269670914
   PubMed Web of Science ®Google Scholar
• AnversaPKajsturaJVentricular myocytes are not terminally differentiated in the adult mammalian heartCirc Res19988311149670913
   PubMed Web of Science ®Google Scholar
• BergmannOBhardwajRDBernardSEvidence for cardiomyocyte renewal in humansScience200932459239810219342590
   PubMed Web of Science ®Google Scholar
• MichlerREStem cell therapy for heart failureCardiol Rev201422310511624595173
   PubMed Web of Science ®Google Scholar
• RanganathSHLevyOInamdarMSKarpJMHarnessing the mesenchymal stem cell secretome for the treatment of cardiovascular diseaseCell Stem Cell201210324425822385653
   PubMed Web of Science ®Google Scholar
• DauweDFJanssensSPStem cell therapy for the treatment of myocardial infarctionCurr Pharm Des201117303328334021919877
   PubMed Web of Science ®Google Scholar
• TengCJLuoJChiuRCShum-TimDMassive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplastyJ Thorac Cardiovasc Surg2006132362863216935119
   PubMed Web of Science ®Google Scholar
• MalliarasKLiTSLuthringerDSafety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cellsCirculation2012125110011222086878
   PubMed Web of Science ®Google Scholar
• Abdel-LatifABolliRTleyjehIMAdult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysisArch Intern Med20071671098999717533201
   PubMedGoogle Scholar
• HofmannMWollertKCMeyerGPMonitoring of bone marrow cell homing into the infarcted human myocardiumCirculation2005111172198220215851598
   PubMed Web of Science ®Google Scholar
• EllisonGMVicinanzaCSmithAJAdult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repairCell2013154482784223953114
   PubMed Web of Science ®Google Scholar
• EllisonGMTorellaDDellegrottaglieSEndogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heartJ Am Coll Cardiol201158997798621723061
   PubMed Web of Science ®Google Scholar
• WaringCDVicinanzaCPapalamprouAThe adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formationEur Heart J201435392722273123100284
   PubMed Web of Science ®Google Scholar
• Nadal-GinardBEllisonGMTorellaDThe cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adultStem Cell Res2014133 Pt B61563024838077
   PubMed Web of Science ®Google Scholar
• HoutgraafJHden DekkerWKvan DalenBMFirst experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarctionJ Am Coll Cardiol201259553954022281257
   PubMed Web of Science ®Google Scholar
• StrauerBEBrehmMZeusTRegeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT StudyJ Am Coll Cardiol20054691651165816256864
   PubMed Web of Science ®Google Scholar
• StammCKleineHDChoiYHIntramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studiesJ Thorac Cardiovasc Surg2007133371772517320570
   PubMed Web of Science ®Google Scholar
• LosordoDWSchatzRAWhiteCJIntramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trialCirculation2007115253165317217562958
   PubMed Web of Science ®Google Scholar
• PovsicTJJungeCNadaAA phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyAm Heart J20131656854861.e223708155
   PubMed Web of Science ®Google Scholar
• van RamshorstJBaxJJBeeresSLIntramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trialJAMA2009301191997200419454638
   PubMed Web of Science ®Google Scholar
• ZhaoQSunYXiaLChenAWangZRandomized study of mononuclear bone marrow cell transplantation in patients with coronary surgeryAnn Thorac Med200886618331840
   Web of Science ®Google Scholar
• AssmusBSchächingerVTeupeCTransplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation2002106243009301712473544
   PubMed Web of Science ®Google Scholar
• MeyerGPWollertKCLotzJIntracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trialCirculation2006113101287129416520413
   PubMed Web of Science ®Google Scholar
• WollertKCMeyerGPLotzJIntracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialLancet2004364942914114815246726
   PubMed Web of Science ®Google Scholar
• LundeKSolheimSAakhusSIntracoronary injection of mononuclear bone marrow cells in acute myocardial infarctionN Engl J Med2006355121199120916990383
   PubMed Web of Science ®Google Scholar
• AssmusBTonnTSeegerFHRed blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapyJ Am Coll Cardiol201055131385139420338501
   PubMed Web of Science ®Google Scholar
• SchächingerVErbsSElsässerAREPAIR-AMI InvestigatorsImproved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialEur Heart J200627232775278317098754
   PubMed Web of Science ®Google Scholar
• TenderaMWojakowskiWRuzyłłoWREGENT InvestigatorsIntracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialEur Heart J200930111313132119208649
   PubMed Web of Science ®Google Scholar
• GyöngyösiMLangIDettkeMCombined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized studyNat Clin Pract Cardiovasc Med200961708119002124
   PubMedGoogle Scholar
• SürderDMankaRLo CiceroVIntracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular functionCirculation2013127191968197923596006
   PubMed Web of Science ®Google Scholar
• TraverseJHHenryTDEllisSGCardiovascular Cell Therapy Research NetworkEffect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trialJAMA2011306192110211922084195
   PubMed Web of Science ®Google Scholar
• TraverseJHHenryTDVaughanDECardiovascular Cell Therapy Research NetworkLateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarctionTex Heart Inst J201037441242020844613
   PubMed Web of Science ®Google Scholar
• MakkarRRSmithRRChengKIntracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trialLancet2012379981989590422336189
   PubMed Web of Science ®Google Scholar
• PerinECSanz-RuizRSánchezPLAdipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE TrialAm Heart J201416818895.e224952864
   PubMed Web of Science ®Google Scholar
• PerinECDohmannHFBorojevicRTransendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failureCirculation2003107182294230212707230
   PubMed Web of Science ®Google Scholar
• PerinECDohmannHFBorojevicRImproved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathyCirculation200411011 Suppl 1II213II21815364865
   PubMed Web of Science ®Google Scholar
• AssmusBFischer-RasokatUHonoldJTOPCARE-CHD RegistryTranscoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD RegistryCirc Res200710081234124117379833
   PubMed Web of Science ®Google Scholar
• HareJMFishmanJEGerstenblithGComparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialJAMA2012308222369237923117550
   PubMed Web of Science ®Google Scholar
• StrauerBEYousefMSchannwellCMThe acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart studyEur J Heart Fail201012772172920576835
   PubMed Web of Science ®Google Scholar
• Fischer-RasokatUAssmusBSeegerFHA pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathyCirc Heart Fail20092541742319808371
   PubMed Web of Science ®Google Scholar
• PatnaikSSWangBWeedBWertheimJALiaoJDecellularized scaffolds: concepts, methodologies, and applications in cardiac tissue engineering and whole-organ regenerationLiuQWangHTissue Regeneration: Where Nanostructure Meets BiologySingaporeWorld Scientific201477124
   Google Scholar
• ZimmermannWMelnychenkoIEschenhagenTEngineered heart tissue for regeneration of diseased heartsBiomaterials20042591639164714697865
   PubMed Web of Science ®Google Scholar
• BursacNPapadakiMCohenRJCardiac muscle tissue engineering: toward an in vitro model for electrophysiological studiesAm J Physiol19992772 Pt 2H433H44410444466
   PubMedGoogle Scholar
• Müller-EhmsenJWhittakerPKlonerRASurvival and development of neonatal rat cardiomyocytes transplanted into adult myocardiumJ Mol Cell Cardiol200234210711611851351
   PubMed Web of Science ®Google Scholar
• ReineckeHMurryCETaking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biologyJ Mol Cell Cardiol200234325125311945017
   PubMed Web of Science ®Google Scholar
• YangYLMotteSKaufmanLJPore size variable type I collagen gels and their interaction with glioma cellsBiomaterials201031215678568820430434
   PubMed Web of Science ®Google Scholar
• ChristmanKLFokHHSieversREFangQLeeRJFibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarctionTissue Eng2004103–440340915165457
   PubMedGoogle Scholar
• LandaNMillerLFeinbergMSEffect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in ratCirculation2008117111388139618316487
   PubMed Web of Science ®Google Scholar
• GiraudMNAyuniECookSSiepeMCarrelTPTevaearaiHTHydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarctionArtif Organs200832969270018684206
   PubMed Web of Science ®Google Scholar
• LuWNLüSHWangHBFunctional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogelTissue Eng Part A20091561437144719061432
   PubMed Web of Science ®Google Scholar
• LutolfMPHubbellJASynthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineeringNat Biotechnol2005231475515637621
   PubMed Web of Science ®Google Scholar
• DobnerSBezuidenhoutDGovenderPZillaPDaviesNA synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodelingJ Card Fail200915762963619700140
   PubMed Web of Science ®Google Scholar
• KloudaLMikosAGThermoresponsive hydrogels in biomedical applicationsEur J Pharm Biopharm2008681344517881200
   PubMed Web of Science ®Google Scholar
• NelsonDMMaZFujimotoKLHashizumeRWagnerWRIntra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challengesActa Biomater20117111520619368
   PubMed Web of Science ®Google Scholar
• LeorJAmsalemYCohenSCells, scaffolds, and molecules for myocardial tissue engineeringPharmacol Ther2005105215116315670624
   PubMed Web of Science ®Google Scholar
• ChristmanKLLeeRJBiomaterials for the treatment of myocardial infarctionJ Am Coll Cardiol200648590791316949479
   PubMed Web of Science ®Google Scholar
• DavisMEHsiehPCGrodzinskyAJLeeRTCustom design of the cardiac microenvironment with biomaterialsCirc Res200597181516002755
   PubMed Web of Science ®Google Scholar
• HuangNFYuJSieversRLiSLeeRJInjectable biopolymers enhance angiogenesis after myocardial infarctionTissue Eng20051111–121860186616411832
   PubMedGoogle Scholar
• ReffelmannTKlonerRACellular cardiomyoplasty – cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure?Cardiovasc Res200358235836812757870
   PubMed Web of Science ®Google Scholar
• KellarRSShepherdBRLarsonDFNaughtonGKWilliamsSKCardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarctTissue Eng20051111–121678168716411813
   PubMedGoogle Scholar
• RobinsonKALiJMathisonMExtracellular matrix scaffold for cardiac repairCirculation20051129 SupplI135I14316159805
   PubMed Web of Science ®Google Scholar
• ZimmermannWHMelnychenkoIWasmeierGEngineered heart tissue grafts improve systolic and diastolic function in infarcted rat heartsNat Med200612445245816582915
   PubMed Web of Science ®Google Scholar
• LeorJTuviaSGuettaVIntracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in SwineJ Am Coll Cardiol200954111014102319729119
   PubMed Web of Science ®Google Scholar
• DetenAVolzHCBriestWZimmerHGCardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in ratsCardiovasc Res200255232934012123772
   PubMed Web of Science ®Google Scholar
• YoshidaMOhHStem cell engineering for cardiac tissue regenerationCardiology2010115319119320145395
   PubMed Web of Science ®Google Scholar
• SingelynJMDeQuachJASeif-NaraghiSBLittlefieldRBSchup-MagoffinPJChristmanKLNaturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineeringBiomaterials200930295409541619608268
   PubMed Web of Science ®Google Scholar
• ZimmermannWHEschenhagenTCardiac tissue engineering for replacement therapyHeart Fail Rev20038325926912878835
   PubMed Web of Science ®Google Scholar
• KutschkaIChenIYKofidisTCollagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat heartsCirculation20061141 SupplI167I17316820568
   PubMed Web of Science ®Google Scholar
• KochMAVrijEJEngelEPlanellJALacroixDPerfusion cell seeding on large porous PLA/calcium phosphate composite scaffolds in a perfusion bioreactor system under varying perfusion parametersJ Biomed Mater Res A20109541011101820872752
   PubMed Web of Science ®Google Scholar
• DvirTTimkoBPBrighamMDNanowired three-dimensional cardiac patchesNat Nanotechnol201161172072521946708
   PubMed Web of Science ®Google Scholar
• BilodeauKMantovaniDBioreactors for tissue engineering: focus on mechanical constraints. A comparative reviewTissue Eng20061282367238316968176
   PubMedGoogle Scholar
• RadisicMMarsanoAMaidhofRWangYVunjak-NovakovicGCardiac tissue engineering using perfusion bioreactor systemsNat Protoc20083471973818388955
   PubMed Web of Science ®Google Scholar
• TandonNMarsanoACannizzaroCVoldmanJVunjak-NovakovicGDesign of electrical stimulation bioreactors for cardiac tissue engineeringConf Proc IEEE Eng Med Biol Soc200820083594359719163486
   PubMedGoogle Scholar
• RadisicMParkHShingHFunctional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffoldsProc Natl Acad Sci U S A200410152181291813415604141
   PubMed Web of Science ®Google Scholar
• DavisMEMotionJPNarmonevaDAInjectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cellsCirculation2005111444245015687132
   PubMed Web of Science ®Google Scholar
• KhaitLBirlaRKCell-based cardiac pumps and tissue-engineered ventriclesRegen Med20072439140617635047
   PubMed Web of Science ®Google Scholar
• LeeEJKim doEAzelogluEUCostaKDEngineered cardiac organoid chambers: toward a functional biological model ventricleTissue Eng Part A200814221522518333774
   PubMed Web of Science ®Google Scholar
• BadylakSFTaylorDUygunKWhole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffoldsAnnu Rev Biomed Eng201113275321417722
   PubMed Web of Science ®Google Scholar
• SingelynJMChristmanKLInjectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matricesJ Cardiovasc Transl Res20103547848620632221
   PubMed Web of Science ®Google Scholar
• Schenke-LaylandKVasilevskiOOpitzFImpact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valvesJ Struct Biol2003143320120814572475
   PubMed Web of Science ®Google Scholar
• MoroniFMirabellaTDecellularized matrices for cardiovascular tissue engineeringAm J Stem Cells20143112024660110
   PubMedGoogle Scholar
• BreuerCKMettlerBAAnthonyTSalesVLSchoenFJMayerJEApplication of tissue-engineering principles toward the development of a semilunar heart valve substituteTissue Eng20041011–121725173615684681
   PubMedGoogle Scholar
• IopLBonettiANasoFDecellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluationPloS One201496e9959324940754
   PubMed Web of Science ®Google Scholar
• OberwallnerBBrodaracAChoiYHPreparation of cardiac extracellular matrix scaffolds by decellularization of human myocardiumJ Biomed Mater Res A201410293263327224142588
   PubMed Web of Science ®Google Scholar
• FreytesDOStonerRMBadylakSFUniaxial and biaxial properties of terminally sterilized porcine urinary bladder matrix scaffoldsJ Biomed Mater Res B Appl Biomater200884240841417618508
   PubMed Web of Science ®Google Scholar
• WangBBorazjaniATahaiMFabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cellsJ Biomed Mater Res A20109441100111020694977
   PubMed Web of Science ®Google Scholar
• WainwrightJMCzajkaCAPatelUBPreparation of cardiac extracellular matrix from an intact porcine heartTissue Eng Part C Methods201016352553219702513
   PubMed Web of Science ®Google Scholar
• OzawaTMickleDAWeiselRDKoyamaNOzawaSLiRKOptimal biomaterial for creation of autologous cardiac graftsCirculation200210612 Suppl 1I176I18212354729
   PubMed Web of Science ®Google Scholar
• WeberBEmmertMYSchoenauerRBrokoppCBaumgartnerLHoerstrupSPTissue engineering on matrix: future of autologous tissue replacementSemin Immunopathol201133330731521279358
   PubMed Web of Science ®Google Scholar
• ZouYZhangYMechanical evaluation of decellularized porcine thoracic aortaJ Surg Res2012175235936821571306
   PubMed Web of Science ®Google Scholar
• SongJJOttHCOrgan engineering based on decellularized matrix scaffoldsTrends Mol Med201117842443221514224
   PubMed Web of Science ®Google Scholar
• ChangYChenSCWeiHJWuTJLiangHCLaiPHTissue regeneration observed in a porous acellular bovine pericardium used to repair a myocardial defect in the right ventricle of a rat modelJ Thorac Cardiovasc Surg2005130370571116153917
   PubMed Web of Science ®Google Scholar
• BadylakSFKochupuraPVCohenISDoroninSVSaltmanAEGilbertTWThe use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardiumCell Transplant200615S29S4016826793
   PubMed Web of Science ®Google Scholar
• OtaTGilbertTWBadylakSFSchwartzmanDZenatiMAElectromechanical characterization of a tissue-engineered myocardial patch derived from extracellular matrixJ Thorac Cardiovasc Surg2007133497998517382638
   PubMed Web of Science ®Google Scholar
• RobinsonKALiJMathisonMRedkarACuiJChronosNAExtracellular matrix scaffold for cardiac repairCirculation20051129SI135I14316159805
   PubMed Web of Science ®Google Scholar
• FuRHWangYCLiuSPDecellularization and recellularization technologies in tissue engineeringCell Transplant2014234–562163024816454
   PubMed Web of Science ®Google Scholar
• AzhimANaritaYMuramatsuKMorimotoYTanakaMDecellularization of living tissue using microwave chemical process for tissue-engineered scaffold applicationsLimCTGohJCInternational Conference on Biomedical Engineering Proceedings. Vol 31, 6th World Congress of Biomechanics (WCB 2010)August 1–6, 2010SingaporeConjunction with 14th International Conference on Biomedical Engineering (ICBME) and 5th Asia Pacific Conference on Biomechanics (APBiomech)Berlin and HeidelbergSpringer2010934937
   Google Scholar
• AkhyariPAubinHGwanmesiaPThe quest for an optimized protocol for whole-heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue engineeringPart C Methods2011179915926
   Web of Science ®Google Scholar
• HeMCallananAComparison of methods for whole-organ decellularization in tissue engineering of bioartificial organsTissue eng Part B Rev201319319420823083305
   PubMed Web of Science ®Google Scholar
• GuyetteJPGilpinSECharestJMTapiasLFRenXOttHCPerfusion decellularization of whole organsNat Protoc201491451146824874812
   PubMed Web of Science ®Google Scholar
• VenkatasubramanianRTGrasslEDBarocasVHLafontaineDBischofJCEffects of freezing and cryopreservation on the mechanical properties of arteriesAnn Biomed Eng200634582383216619131
   PubMed Web of Science ®Google Scholar
• GilbertTWSellaroTLBadylakSFDecellularization of tissues and organsBiomaterials200627193675368316519932
   PubMed Web of Science ®Google Scholar
• ZangMZhangQChangEIMathurABYuPDecellularized tracheal matrix scaffold for tissue engineeringPlast Reconstr Surg2012130353254022929238
   PubMed Web of Science ®Google Scholar
• YangMChenCZWangXNZhuYBGuYJFavorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valvesJ Biomed Mater Res B Appl Biomater200991135436119507136
   PubMed Web of Science ®Google Scholar
• CissellDDHuJCGriffithsLGAthanasiouKAAntigen removal for the production of biomechanically functional, xenogeneic tissue graftsJ Biomech20144791987199624268315
   PubMed Web of Science ®Google Scholar
• WongMLWongJLAthanasiouKAGriffithsLGStepwise solubilization-based antigen removal for xenogeneic scaffold generation in tissue engineeringActa Biomater2013956492650123321301
   PubMed Web of Science ®Google Scholar
• Seif-NaraghiSBSingelynJMSalvatoreMASafety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarctionSci Transl Med20135173173ra125
   Web of Science ®Google Scholar
• WeymannALoganathanSTakahashiHDevelopment and evaluation of a perfusion decellularization porcine heart model – generation of 3-dimensional myocardial neoscaffoldsCirc J201175485286021301134
   PubMed Web of Science ®Google Scholar
• BadylakSFXenogeneic extracellular matrix as a scaffold for tissue reconstructionTranspl Immunol2004123–436737715157928
   PubMed Web of Science ®Google Scholar
• ManjiRAZhuLFNijjarNKGlutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejectionCirculation2006114431832716831988
   PubMed Web of Science ®Google Scholar
• Sánchez FernándezPLFernández SantosMECostanzaSDecelularización de corazones humanos para el desarrollo de matrices cardiacas que sirvan como soporte a la bioingeniería de tejidos cardiacos funcionales [Decellularization of human hearts for the development of heart matrices serve as a support for functional cardiac tissue bioengineering]. Abstract 31Rev Esp Cardiol201164Suppl 34 Spanish
   Google Scholar
• Seif-NaraghiSBSalvatoreMASchup-MagoffinPJHuDPChristmanKLDesign and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineeringTissue Eng Part A20101662017202720100033
   PubMed Web of Science ®Google Scholar
• PaulABinsalamahZMKhanAAA nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapyBiomaterials201132328304831821840594
   PubMed Web of Science ®Google Scholar
• PaulAEliasCBShum-TimDPrakashSBioactive baculovirus nanohybrids for stent based rapid vascular re-endothelializationSci Rep20133236623917680
   PubMed Web of Science ®Google Scholar
• PaulAHasanAKindiHAInjectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repairACS Nano2014888050806224988275
   PubMed Web of Science ®Google Scholar
• PaulAHasanARodesLSangaralingamMPrakashSBioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challengesAdv Drug Deliv Rev20147111513024503281
   PubMed Web of Science ®Google Scholar
• PaulAShaoWAbbasiSShum-TimDPrakashSPAMAM dendrimer-baculovirus nanocomplex for microencapsulated adipose stem cell-gene therapy: in vitro and in vivo functional assessmentMol Pharm2012992479248822817267
   PubMed Web of Science ®Google Scholar
• Vunjak-NovakovicGTandonNGodierAChallenges in cardiac tissue engineeringTissue Eng Part B Rev201016216918719698068
   PubMed Web of Science ®Google Scholar
• SimonPKasimirMTSeebacherGEarly failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patientsEur J Cardiothorac Surg200323610021006 discussion 100612829079
   PubMed Web of Science ®Google Scholar
• SchoenFJLevyRJCalcification of tissue heart valve substitutes: progress toward understanding and preventionAnn Thorac Med200579310721080
   Web of Science ®Google Scholar
• SutherlandFWPerryTEYuYFrom stem cells to viable autologous semilunar heart valveCirculation2005111212783279115927990
   PubMed Web of Science ®Google Scholar
• HawkinsJABreinholtJPLambertLMClass I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patientsJ Thorac Cardiovasc Surg2000119232433010649208
   PubMed Web of Science ®Google Scholar
• LiangRWooSLTakakuraYMoonDKJiaFAbramowitchSDLong-term effects of porcine small intestine submucosa on the healing of medial collateral ligament: a functional tissue engineering studyJ Orthop Res200624481181916514641
   PubMed Web of Science ®Google Scholar
• ShimizuTYamatoMIsoiYFabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfacesCirc Res2002903e4011861428
   PubMed Web of Science ®Google Scholar
• OkanoTYamadaNSakaiHSakuraiYA novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide)J Biomed Mater Res19932710124312518245039
   PubMed Web of Science ®Google Scholar
• KushidaAYamatoMKonnoCKikuchiASakuraiYOkanoTDecrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfacesJ Biomed Mater Res199945435536210321708
   PubMed Web of Science ®Google Scholar
• ShimizuTSekineHYangJPolysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissuesFASEB J200620670871016439619
   PubMed Web of Science ®Google Scholar
• MiyaharaYNagayaNKataokaMMonolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNat Med200612445946516582917
   PubMed Web of Science ®Google Scholar
• MiyagawaSSawaYSakakidaSTissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardiumTransplantation200580111586159516371930
   PubMed Web of Science ®Google Scholar
• MasudaSShimizuTYamatoMOkanoTCell sheet engineering for heart tissue repairAdv Drug Deliv Rev200860227728518006178
   PubMed Web of Science ®Google Scholar
• SekineHShimizuTSakaguchiKIn vitro fabrication of functional three-dimensional tissues with perfusable blood vesselsNat Commun20134139923360990
   PubMed Web of Science ®Google Scholar
• TakahashiKTanabeKOhnukiMInduction of pluripotent stem cells from adult human fibroblasts by defined factorsCell2007131586187218035408
   PubMed Web of Science ®Google Scholar
• DidiéMChristallaPRubartMParthenogenetic stem cells for tissue-engineered heart repairJ Clin Investig201312331285129823434590
   PubMed Web of Science ®Google Scholar
• ZhangJKlosMWilsonGFExtracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich methodCirc Res201211191125113622912385
   PubMed Web of Science ®Google Scholar
• GantzJAPalpantNJWeliksonREHauschkaSDMurryCELaflammeMATargeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cellsPloS One2012710e4697123071682
   PubMed Web of Science ®Google Scholar
• Kita-MatsuoHBarcovaMPrigozhinaNLentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytesPloS One200944e504619352491
   PubMed Web of Science ®Google Scholar
• KehatIKhimovichLCaspiOElectromechanical integration of cardiomyocytes derived from human embryonic stem cellsNat Biotechnol200422101282128915448703
   PubMed Web of Science ®Google Scholar
• ZhangDShadrinIYLamJXianH-QSnodgrassHRBursacNTissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytesBiomaterials201334235813582023642535
   PubMed Web of Science ®Google Scholar
• NunesSSMiklasJWLiuJAschar-SobbiRXiaoYZhangBBiowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytesNat Methods201310878178723793239
   PubMed Web of Science ®Google Scholar
• TullochNLMuskheliVRazumovaMVGrowth of engineered human myocardium with mechanical loading and vascular cocultureCirc Res20111091475921597009
   PubMed Web of Science ®Google Scholar
• KlugMGSoonpaaMHKohGYFieldLJGenetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac graftsJ Clin Invest19969812162248690796
   PubMed Web of Science ®Google Scholar
• KawamuraMMiyagawaSMikiKFeasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy modelCirculation201312611 Suppl 1S29S3722965990
   PubMed Web of Science ®Google Scholar
• MikiKUenakaHSaitoABioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in ratsStem Cells Transl Med20121543043723197822
   PubMed Web of Science ®Google Scholar
• StevensKRKreutzigerKLDuprasSKPhysiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissueProc Natl Acad Sci U S A200910639165681657319805339
   PubMed Web of Science ®Google Scholar
• JanssensSDuboisCBogaertJAutologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialLancet2006367950511312116413875
   PubMed Web of Science ®Google Scholar
• HuikuriHVKervinenKNiemeläMFINCELL InvestigatorsEffects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarctionEur Heart J200829222723273218845667
   PubMed Web of Science ®Google Scholar
• HirschANijveldtRvan der VleutenPAHEBE InvestigatorsIntracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trialEur Heart J201132141736174721148540
   PubMed Web of Science ®Google Scholar
• TraverseJHHenryTDPepineCJCardiovascular Cell Therapy Research Network (CCTRN)Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJAMA2012308222380238923129008
   PubMed Web of Science ®Google Scholar
• PerinECWillersonJTPepineCJCardiovascular Cell Therapy Research Network (CCTRN)Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialJAMA2012307161717172622447880
   PubMed Web of Science ®Google Scholar
• DuckersHJHoutgraafJHehrleinCFinal results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trialEuroIntervention20116780581221252013
   PubMed Web of Science ®Google Scholar
• DibNDinsmoreJLababidiZOne-year follow-up of feasibility and safety of the first US, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study)JACC Cardiovasc Interv20092191619463392
   PubMed Web of Science ®Google Scholar
• AngKLChinDLeyvaFRandomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG aloneNat Clin Pract Cardiovasc Med200851066367018711405
   PubMedGoogle Scholar
• LosordoDWHenryTDDavidsonCACT34-CMI InvestigatorsIntramyocardial, autologous CD34+ cell therapy for refractory anginaCirc Res2011109442843621737787
   PubMed Web of Science ®Google Scholar
• BartunekJBehfarADolatabadiDCardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologicsJ Am Coll Cardiol201361232329233823583246
   PubMed Web of Science ®Google Scholar
• CastaldoCDi MeglioFMiragliaRCardiac fibroblast-derived extracellular matrix (biomatrix) as a model for the studies of cardiac primitive cell biological properties in normal and pathological adult human heartBiomed Res Int2013201335237023738325
   PubMed Web of Science ®Google Scholar
• ChamberlandCMartinez-FernandezABeraldiRNelsonTJEmbryonic decellularized cardiac scaffold supports embryonic stem cell differentiation to produce beating cardiac tissueISRN Stem Cells201420142014 Article ID 625164
   Google Scholar